Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical results and open questions-Reference-Cited by-同舟云学术

Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical results and open questions

Published:2013-09 Issue:9 Volume:13 Page:1035-1043
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Lengfelder Eva,Hofmann Wolf-Karsten,Nowak Daniel

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737140.2013.833681

Reference74 articles.

1. The International Agency for Research on Cancer. WHO classification of tumours of haemopoietic and lymphoid tissues. WHO Press, Lyon 112–114 (2008).

2. 15/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIA

3. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus

4. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML

5. Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Mechanisms of Arsenic Trioxide (Pishuang) in Hepatocellular Carcinoma Based on Network Pharmacology;Evidence-Based Complementary and Alternative Medicine;2021-11-29

2. Epigenetic Dietary Interventions for Prevention of Cancer;Epigenetics of Cancer Prevention;2019

3. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells;Biochemical and Biophysical Research Communications;2016-01

4. Prohibitin promotes apoptosis of promyelocytic leukemia induced by arsenic sulfide;International Journal of Oncology;2015-10-22

5. A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation;Journal of Biomolecular Screening;2015-06-24